{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T22:52:41Z","timestamp":1762296761813},"reference-count":37,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2004,3,1]],"date-time":"2004-03-01T00:00:00Z","timestamp":1078099200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2004,3]]},"DOI":"10.1016\/j.intimp.2004.01.011","type":"journal-article","created":{"date-parts":[[2004,1,30]],"date-time":"2004-01-30T05:15:37Z","timestamp":1075439737000},"page":"419-428","source":"Crossref","is-referenced-by-count":17,"title":["Buprenorphine produces naltrexone reversible alterations of immune status"],"prefix":"10.1016","volume":"4","author":[{"given":"Kelly A.","family":"Carrigan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy B.","family":"Saurer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephanie G.","family":"Ijames","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donald T.","family":"Lysle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2004.01.011_BIB1","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/0028-3908(90)90096-A","article-title":"Morphine inhibition of lymphocyte activity is mediated by an opioid dependent mechanism","volume":"29","author":"Bayer","year":"1990","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.intimp.2004.01.011_BIB2","doi-asserted-by":"crossref","first-page":"7114","DOI":"10.1073\/pnas.83.18.7114","article-title":"Involvement of brain opiate receptors in the immune-suppressive effect of morphine","volume":"83","author":"Shavit","year":"1986","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.intimp.2004.01.011_BIB3","first-page":"913","article-title":"Morphine pellet-induced immunomodulation in mice: temporal relationships","volume":"245","author":"Bryant","year":"1988","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.intimp.2004.01.011_BIB4","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1016\/0024-3205(75)90458-0","article-title":"Effects of certain abused drugs on hemolysin forming cells","volume":"17","author":"Lefkowitz","year":"1975","journal-title":"Life Sci."},{"key":"10.1016\/j.intimp.2004.01.011_BIB5","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1006\/brbi.1994.1003","article-title":"Morphine-induced decreases in in vivo antibody responses","volume":"8","author":"Lockwood","year":"1994","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.intimp.2004.01.011_BIB6","doi-asserted-by":"crossref","first-page":"106","DOI":"10.3181\/00379727-142-36968","article-title":"Interferon inhibition by narcotic analgesics","volume":"142","author":"Hung","year":"1973","journal-title":"Proc. Soc. Exp. Biol. Med."},{"key":"10.1016\/j.intimp.2004.01.011_BIB7","first-page":"1071","article-title":"Morphine-induced alterations of immune status: dose-dependency, compartment specificity and antagonism by naltrexone","volume":"265","author":"Lysle","year":"1993","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.intimp.2004.01.011_BIB8","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/S1567-5769(01)00020-0","article-title":"Morphine-6\u03b2-glucuronide induces potent immunomodulation","volume":"1","author":"Carrigan","year":"2001","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.intimp.2004.01.011_BIB9","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1023\/A:1010924320902","article-title":"Morphine-6\u03b2-glucuronide modulates the expression of inducible nitric oxide synthase","volume":"25","author":"Lysle","year":"2001","journal-title":"Inflammation"},{"key":"10.1016\/j.intimp.2004.01.011_BIB10","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1006\/brbi.1999.0575","article-title":"Involvement of central \u03bc but not \u03b4- or \u03ba-opioid receptors in immunomodulation","volume":"14","author":"Nelson","year":"2000","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.intimp.2004.01.011_BIB11","first-page":"144","article-title":"Further demonstration of kappa opioid binding sites in brain: evidence for heterogeneity","volume":"232","author":"Su","year":"1985","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.intimp.2004.01.011_BIB12","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/0376-8716(85)90067-5","article-title":"Buprenorphine","volume":"14","author":"Lewis","year":"1985","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.intimp.2004.01.011_BIB13","first-page":"109","article-title":"Oral tramadol and buprenorphine in tumour pain. An Italian multicentre trial","volume":"16","author":"Brema","year":"1996","journal-title":"Int. J. Clin. Pharmacol. Res."},{"key":"10.1016\/j.intimp.2004.01.011_BIB14","first-page":"1127","article-title":"Ligand-induced change in surface mu opioid receptor number: relationship to G protein activation?","volume":"292","author":"Zaki","year":"2000","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.intimp.2004.01.011_BIB15","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1074\/jbc.272.2.782","article-title":"Differential opioid agonist regulation of the mouse mu opioid receptor","volume":"272","author":"Blake","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.intimp.2004.01.011_BIB16","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0361-9230(00)00448-2","article-title":"Agonists determine the pattern of G-protein activation in mu-opioid receptor mediated supraspinal analgesia","volume":"54","author":"Sanchez-Blazquez","year":"2001","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.intimp.2004.01.011_BIB17","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/0014-2999(91)90485-9","article-title":"Buprenorphine and morphine cause antinociception by different transduction mechanisms","volume":"195","author":"Wheeler-Aceto","year":"1991","journal-title":"Eur. J. Pharm."},{"key":"10.1016\/j.intimp.2004.01.011_BIB18","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0162-3109(00)00198-3","article-title":"Differential effects of buprenorphine and morphine on immune and neuroendocrine functions following acute administration in the rat mesencephalon periaqueductal gray","volume":"48","author":"Gomez-Flores","year":"2000","journal-title":"Immunopharmacology"},{"key":"10.1016\/j.intimp.2004.01.011_BIB19","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1007\/BF02342227","article-title":"Effect of mu opioids, morphine and buprenorphine on the development of adjuvant arthritis in rats","volume":"45","author":"Walker","year":"1996","journal-title":"Inflamm. Res."},{"issue":"3\u20134","key":"10.1016\/j.intimp.2004.01.011_BIB20","first-page":"157","article-title":"Haematological changes in buprenorphine-treated mice","volume":"45","author":"Bannerjee","year":"1997","journal-title":"Folia Biol."},{"key":"10.1016\/j.intimp.2004.01.011_BIB21","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1258\/002367799780487887","article-title":"Interference of pain control employing opioids in in vivo immunological experiments","volume":"33","author":"Piersma","year":"1999","journal-title":"Lab. Anim."},{"key":"10.1016\/j.intimp.2004.01.011_BIB22","first-page":"620","article-title":"Comparison of the time course of morphine's analgesic and immunologic effects","volume":"85","author":"Nelson","year":"1997","journal-title":"Anesth. Analg."},{"key":"10.1016\/j.intimp.2004.01.011_BIB23","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1007\/s002130100821","article-title":"Importance of sex and relative efficacy at the mu opioid receptor in the development of tolerance and cross-tolerance to the antinociceptive effects of opioids","volume":"158","author":"Barrett","year":"2001","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.intimp.2004.01.011_BIB24","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1007\/s002130000453","article-title":"Sex-related differences in the antinociceptive effects of opioids: importance of rat genotype, nociceptive stimulus intensity, and efficacy at the mu opioid receptor","volume":"150","author":"Cook","year":"2000","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.intimp.2004.01.011_BIB25","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/0022-1759(84)90154-6","article-title":"The standardization of NK cell assay for studies of biological response modifiers","volume":"68","author":"Pross","year":"1984","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.intimp.2004.01.011_BIB26","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1006\/cimm.2000.1653","article-title":"Heroin-induced alterations in leukocyte numbers and apoptosis in the rat spleen","volume":"202","author":"Fecho","year":"2000","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.intimp.2004.01.011_BIB27","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/0162-3109(94)00052-H","article-title":"Pretreatment of beta-funaltrexamine blocks morphine-mediated suppression of CTL activity in alloimmunized mice","volume":"29","author":"Carpenter","year":"1995","journal-title":"Immunopharmacology"},{"key":"10.1016\/j.intimp.2004.01.011_BIB28","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1073\/pnas.88.2.360","article-title":"Immunomodulatory activity of \u03bc- and \u03ba-selective opioid agonists","volume":"88","author":"Taub","year":"1991","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.intimp.2004.01.011_BIB29","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0165-5728(97)00106-9","article-title":"Conditioned immunomodulation: investigations of the role of endogenous activity at mu, kappa, and delta opioid receptor subtypes","volume":"79","author":"Perez","year":"1997","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.intimp.2004.01.011_BIB30","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/978-1-4684-5925-8_22","article-title":"The effect of morphine and DAGO on the proliferative response of murine splenocytes","volume":"288","author":"Eisenstein","year":"1991","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.intimp.2004.01.011_BIB31","first-page":"1079","article-title":"Evidence for beta-adrenergic receptor involvement in the immunomodulatory effects of morphine","volume":"265","author":"Fecho","year":"1993","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.intimp.2004.01.011_BIB32","first-page":"633","article-title":"Evidence for sympathetic and adrenal involvement in the immunomodulatory effects of acute morphine treatment in rats","volume":"277","author":"Fecho","year":"1996","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.intimp.2004.01.011_BIB33","first-page":"1336","article-title":"Immunosuppression by morphine is mediated by central pathways","volume":"267","author":"Hernandez","year":"1993","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.intimp.2004.01.011_BIB34","first-page":"626","article-title":"Assessment of the involvement of central nervous system and peripheral opioid receptors in the immunomodulatory effects of acute morphine treatment in rats","volume":"276","author":"Fecho","year":"1996","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.intimp.2004.01.011_BIB35","first-page":"1533","article-title":"Evidence for the involvement of the caudal region of the periaqueductal gray in a subset of morphine-induced alterations of immune status","volume":"277","author":"Lysle","year":"1996","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.intimp.2004.01.011_BIB36","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1126\/science.2749256","article-title":"The periaqueductal gray matter mediates opiate-induced immunosuppression","volume":"245","author":"Weber","year":"1989","journal-title":"Science"},{"key":"10.1016\/j.intimp.2004.01.011_BIB37","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/0167-0115(94)90418-9","article-title":"Mutagenesis reveals that agonists and peptide antagonists bind in fundamentally distinct manners to the rat mu opioid receptor than do nonpeptide antagonists","volume":"54","author":"Heerding","year":"1994","journal-title":"Regul. Pept."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576904000165?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576904000165?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,15]],"date-time":"2019-02-15T04:24:29Z","timestamp":1550204669000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576904000165"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,3]]},"references-count":37,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2004,3]]}},"alternative-id":["S1567576904000165"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2004.01.011","relation":{},"ISSN":["1567-5769"],"issn-type":[{"type":"print","value":"1567-5769"}],"subject":[],"published":{"date-parts":[[2004,3]]}}}